Zentalis Pharmaceuticals, Inc. (ZNTL) AI Dilution Summary

Estimated cash was $241,367,033 as of 2026-08-17, rolled forward from $174,608,000 at 2026-06-30 against estimated monthly burn of $12,412,000. The most recent raise was a public offering closed 2026-08-17: 26,450,000 shares at $3.50 for $92,575,000 gross and $86,400,000 net. Dilution here is driven primarily by shelf registration S-3 333-286122.